Levofloxacin Injection, Solution
Product Images NDC 68083-395

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 68083-395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levofloxacin_spl_carton_20 mL (Levofloxacinsplcarton20 mL)

Box packaging label for LEVOFLOXACIN Injection 500 mg/20 mL (25 mg/mL) intravenous injection solution. The label indicates the product is for intravenous infusion with further dilution required. It is a 20 mL single-dose vial labeled by Gland Pharma Limited. The label includes storage instructions, directions for use, and a barcode.*

FDA Label Image

Levofloxacin_spl_carton_30 mL (Levofloxacinsplcarton30 mL)

Packaging label for Levofloxacin Injection 750 mg/30 mL (25 mg/mL) intravenous infusion solution by Gland Pharma Limited. The label indicates this is a single-dose 30 mL vial requiring further dilution before intravenous use. Directions for use, storage conditions, manufacturer address, and barcode are also included on the label.*

FDA Label Image

Levofloxacin_spl_image_1 (Levofloxacinsplimage1)

A line graph showing plasma concentration (µg/mL) of levofloxacin over time (hours) comparing 750 mg tablet oral administration versus 750 mg intravenous infusion (90 min). Plasma concentration peaks rapidly after infusion and declines over 36 hours for both routes.*

FDA Label Image

Levofloxacin_spl_image_2 (Levofloxacinsplimage2)

A pharmacokinetic graph showing plasma concentration (µg/mL) over time (hours) for 500 mg levofloxacin administered as a tablet orally (p.o.) and intravenously (i.v.). The graph compares plasma levels between the two administration routes over a 36-hour period.*

FDA Label Image

Levofloxacin_spl_structure (Levofloxacinsplstructure)

Chemical structure of levofloxacin, illustrating its molecular configuration including a fluorine atom, piperazine ring, and carboxylic acid group, along with a hydrate form indicated by 1/2 H2O.*

FDA Label Image

Levofloxacin_spl_vial_20 mL (Levofloxacinsplvial20 mL)

Label for Levofloxacin Injection 500 mg/20 mL (25 mg/mL) single-dose vial for intravenous use. Contains directions for use, storage instructions, and manufacturer information: Gland Pharma Limited, Hyderabad, India. Includes barcode and NDC 68083-394-01.*

FDA Label Image

Levofloxacin_spl_vial_30 mL (Levofloxacinsplvial30 mL)

Label for Levofloxacin Injection 750 mg/30 mL (25 mg/mL) solution for intravenous infusion by Gland Pharma Limited. The single-dose vial requires further dilution before administration. The label includes storage conditions and pharmacist dispensing instructions, along with barcodes and manufacturer details from Hyderabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.